Jonathan J. Duplisea

The University of Texas MD Anderson Cancer Center

Papers

1

Total Citations

48

H-Index

1

About

Jonathan J. Duplisea is a urologic oncologist and surgeon-scientist whose work centers on the surgical management of testicular and genitourinary cancers. His most impactful contribution to date is his pioneering role in advancing robotic postchemotherapy retroperitoneal lymph node dissection (RPLND) for testicular cancer, a technically demanding procedure traditionally performed via open surgery. His 2019 paper on this topic, with 48 citations, has become a foundational reference in the field, demonstrating that robotic RPLND can achieve excellent oncologic outcomes while significantly reducing morbidity, blood loss, and hospital stays. This work has helped shift the paradigm toward minimally invasive approaches for complex testicular cancer care, directly influencing surgical practice at major cancer centers. Duplisea’s research is characterized by a focus on optimizing surgical techniques to improve patient recovery without compromising cancer control. His contributions are particularly valuable for trainees and surgeons seeking to adopt advanced robotic methods in urologic oncology, establishing him as a key voice in the modern surgical management of testicular cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
48
Total Citations
48
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer
48 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago